$ATNM Actimab-A has shown to improved ORR for Venetoclax over 55% in elderly AML. this incredible results. $rhhby $jnj $bmy $mrk $pfe $abbv $amgn $gild $sny $gsk $vrtx $sgen $bmrn $halo $tgtx $tril #Pennystocks @genentech $aveo https://t.co/fkxyakkqmf